Tuesday, 27 September 2022

Biden Medicare costs victory due mostly to Alzheimer's drug change

Biden Medicare costs victory due mostly to Alzheimer's drug change

U.S. President Joe Biden claimed victory on Tuesday for a drop in costs for tens of millions of Americans covered by the Medicare health program, though it is primarily due to a decision to severely limit coverage of an expensive, new Alzheimer's drug.

Europe's generic drugmakers may cut output due to surging energy bills

Europe's drug makers have warned they may stop making some cheap generic medicines because of surging electricity costs and are calling for an overhaul of the way they are priced, the latest industry to seek help as the energy crisis deepens.

Nigeria's northwest faces worsening malnutrition - MSF

Nigeria faces worsening malnutrition in the northwest due to insecurity, high food prices and the impact of climate change, Medicines Sans Frontiers (MSF) said on Tuesday, calling for the region to be included in United Nations funding plans next year.

U.S. FDA to review fewer emergency use requests for COVID tests

The U.S. Food and Drug Administration said on Tuesday it will now review only a small number of emergency use authorization requests for COVID tests that are likely to have a significant benefit to public health, including fulfilling an unmet need.

In Syria, mounting cholera cases pose threat across frontlines

A cholera outbreak that has claimed 29 lives in Syria is posing a danger across the frontlines of the country's 11-year-long war, stirring fears in crowded camps for the displaced who lack running water or sewage systems.

Newsletter H236 x W452.png
Sponsored by Roche: Where you live should not determine if you live

Our panel, featuring Apl.De.AP, Dr Ratna Devi and Muniba Mazari engaged in a lively discussion on improving access to healthcare in Asia

Watch our LifeTalk now!

Japan's COVID herd immunity near 90% after Omicron wave, study says

Japan's population level immunity to COVID-19 has reached about 90% in major population areas after a recent Omicron wave, though that level of protection is likely to diminish in a matter of months, according to a study published on Tuesday.

Congo declares end of latest Ebola outbreak in east

Democratic Republic of Congo has declared the end of its latest Ebola virus outbreak in the eastern province of North Kivu, Health Minister Jean-Jacques Mbungani Mbanda said in a statement on Tuesday.

U.S. FDA puts Avidity's muscle disorder drug trial on partial hold

Avidity Biosciences Inc said on Tuesday the U.S. Food and Drug Administration has put a hold on patient enrollment in an early-to-mid-stage trial of its drug to treat a genetic muscle disorder, sending the company's shares down over 15%.

India's Torrent Pharma to acquire Sequoia-backed Curatio Health for $245 million

Torrent Pharmaceuticals Ltd said on Tuesday it will buy dermatology company Curatio Health Care (I) Pvt Ltd for 20 billion Indian rupees ($245.22 million).

China reports 968 new COVID cases for Sept 26 vs 999 a day earlier

China reported 968 new COVID-19 infections on Sept. 26, of which 245 were symptomatic and 723 were asymptomatic, the National Health Commission said on Tuesday.

Related Videos

Hong Kong to scrap COVID hotel quarantine

End of COVID pandemic is 'in sight' -WHO chief

Millions locked-down in Shenzen over COVID fears